CELL-DYN
®
3200 System Operator’s Manual
4-17
9140181H—October 2001
Section 4
Performance Characteristics and Specifications
Abnormalities
The following tables present a list of abnormalities targeted during this evaluation
and the resultant data.
Table 4.16 lists the various types of specimens that the sites attempted to collect
during this evaluation:
Table 4.16 Abnormalities
1. RBC count <4.00 M/mL
19. Lipemic
2. RBC count >6.20 M/mL
20. Basophils >3%
3. WBC count <4.0 K/mL
21. Icteric
4. WBC count >11.0 K/mL
22. Hemoglobinopathies S and C
5. WBC count >100.0 K/mL
23. Containing macrocytic PLTs
6. PLT count <150 K/mL
24. Uremic
7. PLT count >450 K/mL
25. Paraproteinemia
8. MCV <60 fL
26. Patients on immunosuppressant therapy
9. MCV >110 fL
27. Containing cryoglobulins
10. Containing RBCs resistant to lysis
28. Containing micro clots
11. Containing agranular neutrophils
29. Containing cell fragments
12. Containing variant lymphocytes
30. Platelet satellitosis condition
13. Containing lymphoblasts
31. Containing cold agglutinins
14. Containing bands >5%
32. Containing dual RBC populations
15. Immature granulocytes (myelos, metas, pros)
33. Containing Heinz and Howell-Jolly Bodies
16. Containing myeloblasts/monoblasts
34. Containing Malarial Parasites
17. Containing > 1 NRBC per 100 WBCs
35. Containing >5.0% Reticulocytes
18. Hypogranular eosinophils
36. Chronic Lymphocytic Leukemia (CLL)